The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury

por Sammour, Ibrahim, Somashekar, Santhosh, Huang, Jian, Batlahally, Sunil, Breton, Matthew, Valasaki, Krystalenia, Khan, Aisha, Wu, Shu, Young, Karen C.
Publicado 2016

A novel cardiomyogenic role for Isl1(+) neural crest cells in the inflow tract

por Hatzistergos, Konstantinos E., Durante, Michael A., Valasaki, Krystalenia, Wanschel, Amarylis C. B. A., Harbour, J. William, Hare, Joshua M.
Publicado 2020

Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia

por Benny, Merline, Courchia, Benjamin, Shrager, Sebastian, Sharma, Mayank, Chen, Pingping, Duara, Joanne, Valasaki, Krystalenia, Bellio, Michael A, Damianos, Andreas, Huang, Jian, Zambrano, Ronald, Schmidt, Augusto, Wu, Shu, Velazquez, Omaida C, Hare, Joshua M, Khan, Aisha, Young, Karen C
Publicado 2022

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction

por Rieger, Angela C, Tompkins, Bryon A, Natsumeda, Makoto, Florea, Victoria, Banerjee, Monisha N, Rodriguez, Jose, Rosado, Marcos, Porras, Valeria, Valasaki, Krystalenia, Takeuchi, Lauro M, Collon, Kevin, Desai, Sohil, Bellio, Michael A, Khan, Aisha, Kashikar, Nilesh D, Landin, Ana Marie, Hardin, Darrell V, Rodriguez, Daniel A, Balkan, Wayne, Hare, Joshua M, Schulman, Ivonne Hernandez
Publicado 2022

The Interdisciplinary Stem Cell Institute’s Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseas...

por Khan, Aisha, Bellio, Michael A., Schulman, Ivonne H., Levi, Allan D., Longsomboon, Bangon, Brooks, Adriana, Valasaki, Krystalenia, DiFede, Darcy L., Pujol, Marietsy V., Yavagal, Dileep R., Bates, Karen E., Si, Ming-Sing, Kaushal, Sunjay, Green, Barth A., Anderson, Kimberly D., Guest, James D., Burks, Stephen Shelby, Silvera, Risset, Santamaria, Andrea J., Lalwani, Anil, Dietrich, W. Dalton, Hare, Joshua M.
Publicado 2021

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

por Tompkins, Bryon A, DiFede, Darcy L, Khan, Aisha, Landin, Ana Marie, Schulman, Ivonne Hernandez, Pujol, Marietsy V, Heldman, Alan W, Miki, Roberto, Goldschmidt-Clermont, Pascal J, Goldstein, Bradley J, Mushtaq, Muzammil, Levis-Dusseau, Silvina, Byrnes, John J, Lowery, Maureen, Natsumeda, Makoto, Delgado, Cindy, Saltzman, Russell, Vidro-Casiano, Mayra, Da Fonseca, Moisaniel, Golpanian, Samuel, Premer, Courtney, Medina, Audrey, Valasaki, Krystalenia, Florea, Victoria, Anderson, Erica, El-Khorazaty, Jill, Mendizabal, Adam, Green, Geoff, Oliva, Anthony A, Hare, Joshua M
Publicado 2017

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty

por Golpanian, Samuel, DiFede, Darcy L, Khan, Aisha, Schulman, Ivonne Hernandez, Landin, Ana Marie, Tompkins, Bryon A, Heldman, Alan W, Miki, Roberto, Goldstein, Bradley J, Mushtaq, Muzammil, Levis-Dusseau, Silvina, Byrnes, John J, Lowery, Maureen, Natsumeda, Makoto, Delgado, Cindy, Saltzman, Russell, Vidro-Casiano, Mayra, Pujol, Marietsy V, Da Fonseca, Moisaniel, Oliva, Anthony A, Green, Geoff, Premer, Courtney, Medina, Audrey, Valasaki, Krystalenia, Florea, Victoria, Anderson, Erica, El-Khorazaty, Jill, Mendizabal, Adam, Goldschmidt-Clermont, Pascal J, Hare, Joshua M
Publicado 2017